Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1369798 | Bioorganic & Medicinal Chemistry Letters | 2012 | 6 Pages |
The structure–activity relationships of new Aurora A/B kinase inhibitors derived from the previously identified kinase inhibitor 12 are described. Introduction of acetic acid amides onto the pyrazole of compound 12 was postulated to influence Aurora A/B selectivity and improve the profile against off-target kinases. The SAR of the acetic acid amides was explored and the effect of substitution on enzyme inhibition as well as mechanism-based cell activity was studied. Additionally, several of the more potent inhibitors were screened for their off-target kinase selectivity.
Graphical abstractPreviously reported Aurora A/B inhibitor 12 was optimized to provide selectivity against a panel of off-target kinases while retaining Aurora A/B potency and good cellular activity.Figure optionsDownload full-size imageDownload as PowerPoint slide